Chang Hao Cui

Title: Chang Hao Cui: Innovator in Pharmaceutical Composition

Introduction

Chang Hao Cui is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating serious health conditions. With a total of three patents to his name, his work is recognized for its potential impact on medical treatments.

Latest Patents

One of Chang Hao Cui's latest patents is a composition for preventing or treating vascular leak syndrome. This invention relates to a pharmaceutical composition containing ginsenoside F1 or Rh1, which is designed to prevent or treat vascular leak syndrome. The composition promotes angiogenesis and suppresses vascular leakage, making it a promising candidate for effective treatment options. Another significant patent involves a composition for preventing or treating cervical cancer, which includes gypenoside LXXV as an active ingredient. This pharmaceutical composition aims to prevent or treat cervical cancer and can be administered to subjects excluding humans, showcasing its versatility in health applications.

Career Highlights

Chang Hao Cui is affiliated with the Intelligent Synthetic Biology Center, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a strong focus on utilizing natural compounds for therapeutic purposes, which reflects a growing trend in the pharmaceutical industry.

Collaborations

Chang Hao Cui collaborates with esteemed colleagues such as Sun Chang Kim and Wan Taek Im. Their combined expertise contributes to the advancement of research and development in synthetic biology and pharmaceuticals.

Conclusion

Chang Hao Cui's contributions to pharmaceutical compositions highlight his role as an influential inventor in the medical field. His innovative approaches to treating vascular leak syndrome and cervical cancer demonstrate the potential of natural compounds in modern medicine.